title: Use of Cox regression with treatment status as a time-dependent covariate to re-analyze survival benefit excludes immortal time bias effect in patients with glioblastoma who received prolonged adjuvant treatment with valganciclovir.
authors: Department of Medicine Solna Unit for Experimental Medicine Cell and Molecular Immunology, Center for Molecular Medicine, Karolinska Institute, Stockholm, Sweden.
authors: Cecilia
authors: C
authors: Söderberg-Naucler
authors: Inti
authors: I
authors: Peredo
authors: Afsar
authors: A
authors: Rahbar
authors: Fredrik
authors: F
authors: Hansson
authors: Anders
authors: A
authors: Nordlund
authors: Giuseppe
authors: G
authors: Stragliotto
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000821:virology*; D003587:Cytomegalovirus / Q000187:drug effects*; D005260:Female; D015774:Ganciclovir / Q000031:analogs & derivatives*; D005909:Glioblastoma / Q000821:virology*; D006801:Humans; D008297:Male
chemical_list: D000998:Antiviral Agents; D015774:Ganciclovir